MEDICILASNE: what changed
MEDICILASNE
Largest movements
- Cash +€37,265
up €37,265 (+14.2%), from €262,832 to €300,097
mainly Net result for the year (+€58,352) and Depreciation (+€5,667)
- Receivables within one year +€13,691
up €13,691 (+22.7%), from €60,258 to €73,949
- Current investments +€12,517
up €12,517 (+6.3%), from €198,127 to €210,645
- Reserves +€58,352
up €58,352 (+12.5%), from €466,462 to €524,814
of which Distributable reserves: +€58,352
- Gross operating margin -€14,992
down €14,992 (-14.0%), from €106,793 to €91,801
- Taxes +€7,452
up €7,452 (+25.7%), from €28,954 to €36,407
- Depreciation -€6,802
down €6,802 (-54.6%), from €12,469 to €5,667
- Financial charges -€1,882
down €1,882 (-81.1%), from €2,319 to €438
- Financial income +€1,262
up €1,262 (+15.4%), from €8,200 to €9,462
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €564,656 | €622,973 | +€58,317 | +10.3% |
| Fixed assets | 21/28 | €14,129 | €8,462 | -€5,667 | -40.1% |
| Tangible fixed assets | 22/27 | €12,158 | €6,491 | -€5,667 | -46.6% |
| Furniture and vehicles | 24 | €12,158 | €6,491 | -€5,667 | -46.6% |
| Financial fixed assets | 28 | €1,971 | €1,971 | = | 0.0% |
| Current assets | 29/58 | €550,528 | €614,511 | +€63,984 | +11.6% |
| Amounts receivable after more than one year | 29 | €27,074 | €27,837 | +€764 | +2.8% |
| Other amounts receivable | 291 | €27,074 | €27,837 | +€764 | +2.8% |
| Amounts receivable within one year | 40/41 | €60,258 | €73,949 | +€13,691 | +22.7% |
| Other amounts receivable | 41 | €60,258 | €73,949 | +€13,691 | +22.7% |
| Current investments | 50/53 | €198,127 | €210,645 | +€12,517 | +6.3% |
| Cash at bank and in hand | 54/58 | €262,832 | €300,097 | +€37,265 | +14.2% |
| Deferred charges and accrued income | 490/1 | €2,236 | €1,983 | -€253 | -11.3% |
| Total equity and liabilities | 10/49 | €564,656 | €622,973 | +€58,317 | +10.3% |
| Equity | 10/15 | €564,621 | €622,973 | +€58,352 | +10.3% |
| Contributions | 10/11 | €98,159 | €98,159 | = | 0.0% |
| Reserves | 13 | €466,462 | €524,814 | +€58,352 | +12.5% |
| Non-distributable reserves | 130/1 | €10,435 | €10,435 | = | 0.0% |
| Reserves not available under the articles | 1311 | €10,435 | €10,435 | = | 0.0% |
| Distributable reserves | 133 | €456,027 | €514,379 | +€58,352 | +12.8% |
| Amounts payable | 17/49 | €35 | €0 | -€35 | -100% |
| Accrued charges and deferred income | 492/3 | €35 | €0 | -€35 | -100% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €12,469 | €5,667 | -€6,802 | -54.6% |
| Other operating charges | 640/8 | €387 | €400 | +€12 | +3.2% |
| Gross operating margin | 9900 | €106,793 | €91,801 | -€14,992 | -14.0% |
| Operating profit (loss) | 9901 | €93,936 | €85,734 | -€8,202 | -8.7% |
| Financial income | 75/76B | €8,200 | €9,462 | +€1,262 | +15.4% |
| Recurring financial income | 75 | €8,200 | €9,462 | +€1,262 | +15.4% |
| Financial charges | 65/66B | €2,319 | €438 | -€1,882 | -81.1% |
| Recurring financial charges | 65 | €2,319 | €438 | -€1,882 | -81.1% |
| Profit (loss) for the period before taxes | 9903 | €99,817 | €94,759 | -€5,058 | -5.1% |
| Income taxes | 67/77 | €28,954 | €36,407 | +€7,452 | +25.7% |
| Profit (loss) for the period | 9904 | €70,862 | €58,352 | -€12,510 | -17.7% |
| Profit (loss) for the period to be appropriated | 9905 | €70,862 | €58,352 | -€12,510 | -17.7% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 8 November 2026 via checked.be.